An Intra-Articular, Extended-Release Formulation of Triamcinolone Acetonide Prolongs and Amplifies Analgesic Effect in Patients with Osteoarthritis of the Knee

Sustained and profound analgesic benefits in people with osteoarthritis of the knee using FX006, an intra-articular extended-release formulation of triamcinolone acetonide: Results from a double-blind, randomized, parallel-group, dose-ranging study

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2016.01.113 ◽

2016 ◽

Vol 24 ◽

pp. S49-S50 ◽

Author(s):

P.G. Conaghan ◽

S. Cohen ◽

J. Jordan ◽

F. Berenbaum ◽

J. Lufkin ◽

...

Keyword(s):

Triamcinolone Acetonide ◽

Extended Release ◽

Osteoarthritis Of The Knee ◽

Double Blind ◽

Release Formulation ◽

Parallel Group ◽

Dose Ranging

A single intra-articular dose of Fx006, an extended-release formulation of triamcinolone acetonide, has a similar effect on cartilage in healthy dogs as the commonly used kenalog-40® suspension

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2014.02.883 ◽

2014 ◽

Vol 22 ◽

pp. S463-S464

Author(s):

A. Kumar ◽

A. Walz ◽

D. Garlick ◽

C. Spainhour ◽

N. Bodick

Keyword(s):

Triamcinolone Acetonide ◽

Extended Release ◽

Release Formulation ◽

Healthy Dogs

Synovial and systemic pharmacokinetics of triamcinolone acetonide following intra-articular injection of an extended release formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2017.02.744 ◽

2017 ◽

Vol 25 ◽

pp. S431 ◽

Cited By ~ 2

Author(s):

V. Byers-Kraus ◽

H.A. Aazami ◽

P. Mehra ◽

A.J. Kivitz ◽

J. Lufkin ◽

...

Keyword(s):

Knee Osteoarthritis ◽

Triamcinolone Acetonide ◽

Extended Release ◽

Release Formulation ◽

Crystalline Suspension

Extended-release Formulation Attenuates the Impacts of Fluvastatin on Serum PCSK9 Levels in Humans

Letters in Drug Design & Discovery ◽

10.2174/1570180814666161216121558 ◽

2017 ◽

Vol 14 (7) ◽

Author(s):

Yuan-Lin Guo ◽

Wei Zhang ◽

Qian Dong ◽

Geng Liu ◽

Cheng-Gang Zhu ◽

...

Keyword(s):

Extended Release ◽

Release Formulation ◽

A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.362 ◽

2017 ◽

Vol 7 (2) ◽

pp. 151-159 ◽

Author(s):

Ann Childress ◽

Jeffrey G. Stark ◽

Russ McMahen ◽

Dorothy Engelking ◽

Carolyn Sikes

Keyword(s):

Extended Release ◽

Healthy Adults ◽

Release Formulation ◽

Orally Disintegrating Tablets

Novel extended-release formulation of lovastatin by one-step melt granulation: In vitro and in vivo evaluation

European Journal of Pharmaceutics and Biopharmaceutics ◽

10.1016/j.ejpb.2010.11.024 ◽

2011 ◽

Vol 77 (2) ◽

pp. 306-312 ◽

Cited By ~ 19

Author(s):

L. Ochoa ◽

M. Igartua ◽

R.M. Hernández ◽

A.R. Gascón ◽

M.A. Solinis ◽

...

Keyword(s):

Extended Release ◽

In Vivo Evaluation ◽

Release Formulation ◽

One Step ◽

Melt Granulation

IMPURITY PROFILING OF THE ROPINIROLE EXTENDED RELEASE FORMULATION, IDENTIFICATION AND CHARACTERIZATION OF POTENTIAL DEGRADANT

Journal of Liquid Chromatography &amp Related Technologies ◽

10.1080/10826076.2013.850720 ◽

2014 ◽

Vol 37 (17) ◽

pp. 2490-2505 ◽

Author(s):

Palavai Sripal Reddy ◽

A. Malleswara Reddy ◽

S. Jayapal Reddy ◽

Shakil Sait ◽

K. Vyas

Keyword(s):

Extended Release ◽

Release Formulation ◽

Identification And Characterization

Impurity Profiling ◽

Fluvastatin extended-release formulation is effective in treating primary hypercholesterolaemia

Atherosclerosis ◽

10.1016/s0021-9150(00)80341-x ◽

2000 ◽

Vol 151 (1) ◽

pp. 74-75 ◽

Author(s):

W Insull ◽

A.D Marais ◽

R Aronson ◽

S Manfreda

Keyword(s):

Extended Release ◽

Release Formulation ◽

Primary Hypercholesterolaemia ◽

Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment

International Journal of Pharmaceutics ◽

10.1016/j.ijpharm.2021.120329 ◽

2021 ◽

Vol 597 ◽

pp. 120329

Author(s):

Manali Patki ◽

Siddhant Palekar ◽

Sandra Reznik ◽

Ketan Patel

Keyword(s):

Extended Release ◽

Release Formulation ◽

Potential Formulation

The Abuse Potential of Remoxy®, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release Oxycodone

Pain Medicine ◽

10.1111/j.1526-4637.2011.01093.x ◽

2011 ◽

Vol 12 (4) ◽

pp. 618-631 ◽

Cited By ~ 34

Author(s):

Beatrice Setnik ◽

Carl L. Roland ◽

Jody M. Cleveland ◽

Lynn Webster

Keyword(s):

Extended Release ◽

Abuse Potential ◽

Release Formulation ◽